Jun 20, 2019 - Investors need to pay close attention to Regeneron (REGN) stock based on the movements in the options market lately.
Jun 19, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
Jun 18, 2019 - Alnylam (ALNY) completes enrollment in its ILLUMINATE-A phase III study on lumasiran for the treatment of adults and children with primary hyperoxaluria type 1.
Jun 17, 2019 - Regeneron (REGN) reports positive early-stage data on REGN1979 in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma.
Jun 06, 2019 - Alnylam (ALNY) completes the rolling NDA submission to the FDA for givosiran, which is being evaluated for the treatment of acute hepatic porphyria.
Jun 05, 2019 - GlaxoSmithKline (GSK) announces that the EMA???s Committee for Medicinal Products for Human Use has issued a positive opinion for two self-administered options of its asthma drug, Nucala.
May 23, 2019 - Top Analyst Reports for Home Depot, Phillip Morris & United Parcel Service
May 20, 2019 - Adverum's (ADVM) stock gains as the FDA lifts the clinical hold on the second cohort of an initial stage study on lead candidate.
May 16, 2019 - Pfizer's (PFE) investigational eczema treatment abrocitinib succeeds in pivotal late-stage study.
May 15, 2019 - Key highlights of the past week are regulatory and pipeline updates by the leading biotech companies.